Results 211 to 220 of about 71,732 (355)

Efficacy and safety of 2–4 mg brexpiprazole in the management of schizophrenia: A systematic review and meta‐analysis

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
This graphical summary illustrates the efficacy and safety of brexpiprazole (2–4 mg) in patients with schizophrenia. The meta‐analysis demonstrates significant improvement in clinical outcomes, with reductions in Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression ‐ Severity scale (CGI‐S) scores, indicating better symptom ...
Sher Bano   +14 more
wiley   +1 more source

Retraction: Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

open access: gold
Hongxia Chen   +10 more
openalex   +2 more sources

All cells have the capacity to time. [PDF]

open access: yesJ Exp Psychol Anim Learn Cogn
Simpson EH, Balsam PD.
europepmc   +1 more source

An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug [PDF]

open access: bronze, 2003
Takashi Iwasa   +8 more
openalex   +1 more source

Antidepressant-Like Activity of YL-0919: A Novel Combined Selective Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

open access: gold, 2013
Hongxia Chen   +10 more
openalex   +2 more sources

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome. [PDF]

open access: yesCommun Med (Lond)
Mehravar S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy